Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Prepaid Assets: 2018-2024

Historic Prepaid Assets for Whitehawk Therapeutics (WHWK) over the last 7 years, with Dec 2024 value amounting to $2.8 million.

  • Whitehawk Therapeutics' Prepaid Assets fell 9.26% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year decrease of 9.26%. This contributed to the annual value of $2.8 million for FY2024, which is 25.88% down from last year.
  • According to the latest figures from FY2024, Whitehawk Therapeutics' Prepaid Assets is $2.8 million, which was down 25.88% from $3.8 million recorded in FY2023.
  • Over the past 5 years, Whitehawk Therapeutics' Prepaid Assets peaked at $3.8 million during FY2023, and registered a low of $81,000 during FY2020.
  • In the last 3 years, Whitehawk Therapeutics' Prepaid Assets had a median value of $3.7 million in 2022 and averaged $3.5 million.
  • Its Prepaid Assets has fluctuated over the past 5 years, first plummeted by 88.98% in 2020, then surged by 2,718.52% in 2021.
  • Whitehawk Therapeutics' Prepaid Assets (Yearly) stood at $81,000 in 2020, then skyrocketed by 2,718.52% to $2.3 million in 2021, then surged by 64.08% to $3.7 million in 2022, then rose by 2.14% to $3.8 million in 2023, then declined by 25.88% to $2.8 million in 2024.